Sage Journals: Discover world-class research

Abstract

Background: The role of vitamin D receptor (VDR) single-nucleotide polymorphisms (SNPs) in ovarian cancer has been studied in various populations; however, these results are discordant between different ethnicities. Method: Using the polymerase chain reaction-restriction fragment length polymorphism method, we studied the prevalence of the VDR FokI (rs2228570) and BsmI (rs1544410) SNPs in women with ovarian cancer (n=168) and controls (n=182) in a Polish population. Results: We found a significant contribution of the BsmI SNP Bb+BB-versus-bb dominant inheritance model to ovarian cancer development (p=0.0221, p_corr=0.0442, odds ratio [OR]=1.648 [95% confidence intervals, CI=1.073-2.532]). However, we did not observe an association of the BsmI SNP BB versus Bb+bb recessive inheritance model in patients (p=0.8059, OR=1.093 [95% CI=0.538-2.218]). Moreover, there was no association of FokI SNPs either in Ff+ff versus FF dominant or ff versus Ff+FF recessive inheritance models with ovarian cancer development (p=0.9924, OR=1.002 [95% CI=0.628-1.599] and p=0.1123, OR=1.542 [95% CI=0.901-2.638], respectively). The p-values of the trend test observed for the VDR BsmI and FokI SNPs in patients with ovarian cancer were p_trend=0.0613 and p_trend=0.3655, respectively. Conclusion: Our study indicates that the VDR B gene variant might be a moderate risk factor of ovarian cancer development in the Polish population.

Get full access to this article

View all access options for this article.

References

Arai

, Miyamoto

K-I

, Taketani

et al. 1997. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japan women. J Bone Miner Res, 12:915-921.

Arjumand

, Ahmad

, Seth

et al. 2012. Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population. Tumour Biol, 33:23-31.

Bai

, Yu

et al. 2009. Association of vitamin D receptor polymorphisms with the risk of prostate cancer in the Han population of Southern China. BMC Med Genet, 10:125.

Bai

, Lu

, Hong

et al. 2012. Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J Gastroenterol, 18:1672-1679.

Bakhru

, Mallinger

, Buckanovich

et al. 2010. Casting light on 25-hydroxyvitamin D deficiency in ovarian cancer: a study from the NHANES. Gynecol Oncol, 119:314-318.

Brekelmans

. 2003. Risk factors and risk reduction of breast and ovarian cancer. Curr Opin Obstet Gynecol, 15:63-68.

Cheng

, Neuhouser

. 2012. Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient-nutrient interaction. Cancer Causes Control, 23:1557-1565.

Churilla

, Brereton

, Klem

et al. 2012. Vitamin D deficiency is widespread in cancer patients and correlates with advanced stage disease: a community oncology experience. Nutr Cancer, 64:521-525.

Clendenen

, Arslan

, Koenig

et al. 2008. Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett, 260:209-215.

10.

Falleti

, Bitetto

, Fabris

et al. 2010. Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis. World J Gastroenterol, 16:3016-3024.

11.

Gandini

, Raimondi

, Gnagnarella

et al. 2009. Vitamin D and skin cancer: a meta-analysis. Eur J Cancer, 45:634-641.

12.

Grant

. 2012. Ecological studies of the UVB-vitamin D-cancer hypothesis. Anticancer Res, 32:223-236.

13.

Imtiaz

, Siddiqui

, Raza

et al. 2012. Vitamin D deficiency in newly diagnosed breast cancer patients. Indian J Endocrinol Metab, 16:409-413.

14.

Jemal

, Bray

, Center

et al. 2011. Global cancer statistics. CA Cancer J Clin, 61:69-90.

15.

Köstner

, Denzer

, Müller

et al. 2009. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res, 29:3511-3536.

16.

Liu

, Calderon

, Zhang

et al. 2005. Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer. Pharmacogenet Genomics, 15:159-165.

17.

Luo

, Yang

, Wu

et al. 2012. Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population. Lupus, 21:53-59.

18.

Lurie

, Wilkens

, Thompson

et al. 2007. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev, 16:2566-2571.

19.

Lurie

, Wilkens

, Thompson

et al. 2011. Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium. Int J Cancer, 128:936-943.

20.

, Yu

, Su

et al. 2012. Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferol. Cancer, 2012[Epub ahead of print]10.1002/cncr.27531.

21.

Maruotti

, Cantatore

. 2010. Vitamin D and the immune system. J Rheumatol, 37:491-495.

22.

Merritt

, Cramer

, Vitonis

et al. 2012. Dairy foods and nutrients in relation to risk of ovarian cancer and major histological subtypes. Int J Cancer[Epub ahead of print]10.1002/ijc.27701.

23.

Mishra

, Bid

, Srivastava

et al. 2005. Association of vitamin D receptor gene polymorphism and risk of prostate cancer in India. Urol Int, 74:315-318.

24.

Mittal

, Manchanda

, Bhat

et al. 2007. Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population. BJU Int, 99:933-937.

25.

Miyamoto

, Kesterson

, Yamamoto

et al. 1997. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocr, 11:1165-1179.

26.

Monticielo

, Brenol

, Chies

et al. 2012. The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus. Lupus, 21:43-52.

27.

Orell-Kotikangas

, Schwab

, Osterlund

et al. 2012. High prevalence of vitamin D insufficiency in patients with head and neck cancer at diagnosis. Head Neck, 34:1450-1455.

28.

Penna-Martinez

, Ramos-Lopez

, Stern

et al. 2009. Vitamin D receptor polymorphisms in differentiated thyroid carcinoma. Thyroid, 19:623-628.

29.

Pereira

, Larriba

, Muñoz

. 2012. Vitamin D and colon cancer. Endocr Relat Cancer, 19:R51-R71.

30.

Ren

, Qiu

, Wang

et al. 2012. Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. Carcinogenesis, 33:1319-1326.

31.

Romero

, Bast

Jr . 2012. Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy. Endocrinology, 153:1593-1602.

32.

Roskies

, Dolev

, Caglar

et al. 2012. Vitamin d deficiency as a potentially modifiable risk factor for thyroid cancer. J Otolaryngol Head Neck Surg, 41:160-163.

33.

Sueblinvong

, Carney

. 2009. Current understanding of risk factors for ovarian cancer. Curr Treat Options Oncol, 10:67-81.

34.

Swami

, Krishnan

, Wang

et al. 2012. Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. Endocrinology, 153:2576-2587.

35.

Tamez

, Norizoe

, Ochiai

et al. 2009. Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. Br J Cancer, 101:1957-1960.

36.

Tang

, Chen

, Wu

et al. 2009. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat, 117:391-399.

37.

Tworoger

, Gates

, Lee

et al. 2009. Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res, 69:1885-1891.

38.

Uitterlinden

, Fang

, Van Meurs

JBJ

et al. 2004. Genetics and biology of vitamin D receptor polymorphisms. Gene, 338:143-156.

39.

Wolden-Kirk

, Gysemans

, Verstuyf

et al. 2012. Extraskeletal effects of vitamin D. Endocrinol Metab Clin North Am, 41:571-594.

40.

Zhang

, Chalmers

, Stayrook

et al. 2011. DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nat Struct Mol Biol, 18:556-563.

41.

Zhang

, Nicosia

, Bai

. 2006. Vitamin D receptor is a novel drug target for ovarian cancer treatment. Curr Cancer Drug Targets, 6:229-244.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB

Vitamin D Receptor Gene Bsm I and Fok I Polymorphisms in Relation to Ovarian Cancer Risk in the Polish Population

Abstract

Get full access to this article

References

Supplementary Material